CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)
Abstract
Authors
P. Walker J.P. Sharman W. Jurczak T. Munir V. Banerji S. Coutre J. Woyach G. Salles W.G. Wierda P. Patel M.H. Wang U. Emeribe E. Flood J.C. Byrd P. Ghia